Consumer healthcare giant Johnson & Johnson (J&J) has confirmed that it was pulling some versions of infant Tylenol off store shelves in the United States due to problems with new design of the bottles.
The company said it would recall all of the 574,000 redesigned bottles of grape-flavored liquid infant Tylenol.
The redesigned bottles of infant Tylenol included a plastic cover that was designed to make it easier for parents to extract the correct dose of the medicine with a plastic syringe.
But some parents complained that when they slotted the syringe into the top of the bottle, it shoved the cover right into the bottle, making it complicated to gauge the right quantity of the medicine.
Chief executive William Weldon claimed that was nothing incorrect with the medicine itself and that the company issued the latest recall to preserve and reinforce the company’s commitment to patients and consumers.
Since 2009, J&J has issued several recalls, pulling millions of bottles of Tylenol, Benadryl and Motrin off the store shelves due to problems such as metal shavings found in medicines, bad odors and wrong levels of an active ingredient.
- Pressure Mounts to Introduce Meningitis Jabs for Irish Babies
- Sony confirms ‘KitKat’ update for Xperia Z1, Xperia Z1 Compact and Xperia Z Ultra; more devices to follow soon
- Samsung announces its first curved Ultra HD displays
- Zuckerberg, Musk, and Kutcher investing $400 million in AI startup Vicarious
- Amazon reportedly set to launch its own video-streaming device in April